A comparison of Seroquel vs. Risperidone in Schizophrenia
Study identifier:5077US/0043
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
-
Medical condition
schizophrenia
Phase
Phase 4
Healthy volunteers
No
Study drug
quetiapine fumarate vs risperidone
Sex
All
Actual Enrollment
-
Study type
Interventional
Age
18 Years - 65 Years
Date
Study Start Date: 01 Jul 2001
Primary Completion Date: 01 Sept 2002
Study Completion Date: 01 Sept 2002
Study design
Allocation: None
Endpoint Classification: None
Intervention Model: None
Masking: None
Primary Purpose: Treatment
Verification:
Verified 01 Nov 2013 by AstraZeneca
Sponsors
AstraZeneca
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|
